Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ANGO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Stephen A. Trowbridge EVP and CFO | ANGO AngioDynamics, Inc. | Sale | 23,615 | $12.27 | $289.8K Sale | Form 4 ↗ |
| Oct 28, 2026 | Stephen A. Trowbridge EVP and CFO | ANGO AngioDynamics, Inc. | Sale | 1,720 | $12.17 | $20.9K Sale | Form 4 ↗ |
| Jul 30, 2026 | Warren Nighan Jr. SVP Quality and Regulatory | ANGO AngioDynamics, Inc. | Sale | 23,370 | $14.72 | $344.0K Sale | Form 4 ↗ |
| Oct 21, 2025 | Lawrence T. Weiss SVP, Chief Legal Officer | ANGO AngioDynamics, Inc. | Buy | 10,000 | $11.81 | $118.1K Buy | Form 4 ↗ |
| Oct 13, 2025 | Stephen A. Trowbridge EVP and CFO | ANGO AngioDynamics, Inc. | Buy | 890 | $11.16 | $9,932 Buy | Form 4 ↗ |
| Oct 9, 2025 | James C. Clemmer President and CEO, Director | ANGO AngioDynamics, Inc. | Buy | 10,000 | $11.15 | $111.5K Buy | Form 4 ↗ |
| Jan 16, 2025 | Warren Nighan Jr. SVP Quality and Regulatory | ANGO AngioDynamics, Inc. | Sale | 4,060 | $12.31 | $50.0K Sale | Form 4 ↗ |
| Oct 10, 2024 | Warren Nighan Jr. SVP Quality and Regulatory | ANGO AngioDynamics, Inc. | Buy | 100 | $6.08 | $608 Buy | Form 4 ↗ |
| Oct 8, 2024 | Stephen A. Trowbridge EVP and CFO | ANGO AngioDynamics, Inc. | Buy | 1,700 | $5.86 | $9,962 Buy | Form 4 ↗ |
| Oct 7, 2024 | Warren Nighan Jr. SVP Quality and Regulatory | ANGO AngioDynamics, Inc. | Buy | 768 | $6.09 | $4,677 Buy | Form 4 ↗ |
| Oct 7, 2024 | James C. Clemmer President and CEO, Director | ANGO AngioDynamics, Inc. | Buy | 20,000 | $6.03 | $120.6K Buy | Form 4 ↗ |
11 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances